Literature DB >> 9563424

Patient participation in colon cancer screening programs.

A M DiPalma1, S E Barnes, J A DiPalma.   

Abstract

BACKGROUND: The objectives of this study were to survey compliance and identify factors that influence continued participation with periodic colon cancer screening guidelines once patients are seen for their first screening.
METHODS: The study group consisted of 95 patients who had initial fecal occult blood tests (FOBT) and flexible sigmoidoscopy (FS) in 1991 as part of a gastroenterologist-directed, aggressively managed colon cancer screening registry. Regular notices are sent to patients and their primary care provider for annual FOBT and FS at 3- to 5-year intervals.
RESULTS: Of 70 (74%) reviewed, 2 had died and 3 were having colonoscopic surveillance. Thirty-two of the 65 (49%) contacted eligible study subjects were no longer participating. Reasons stated were as follows: unaware that screening was due (14), too busy (6), unpleasant experience (3), and change to insurance provider that did not cover screening (9 [commercial-3, managed care-1, Medicare-5]).
CONCLUSIONS: Despite aggressive program management, 44% of nonparticipators reported that they were unaware that screening was due. Sixteen percent of those who did not continue to participate had graduated to Medicare, which did not cover screening costs. Factors that influence continued participation need to be considered in the design of public education and marketing promotions.

Entities:  

Mesh:

Year:  1998        PMID: 9563424     DOI: 10.1097/00007611-199804000-00005

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.

Authors:  Charlene L Stokamer; Craig T Tenner; Jhuma Chaudhuri; Eva Vazquez; Edmund J Bini
Journal:  J Gen Intern Med       Date:  2005-03       Impact factor: 5.128

2.  Men's knowledge and beliefs about colorectal cancer and 3 screenings: education, race, and screening status.

Authors:  Julie A Winterich; Sara A Quandt; Joseph G Grzywacz; Peter Clark; Mark Dignan; John H Stewart; Thomas A Arcury
Journal:  Am J Health Behav       Date:  2011-09

3.  Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer.

Authors:  Luis Bujanda; Cristina Sarasqueta; Leire Zubiaurre; Angel Cosme; Carmen Muñoz; Araceli Sánchez; Cristina Martín; Llucia Tito; Virginia Piñol; Antoni Castells; Xavier Llor; Rosa M Xicola; Elisenda Pons; Juan Clofent; María L de Castro; Jaime Cuquerella; Enrique Medina; Ana Gutierrez; Juan I Arenas; Rodrigo Jover
Journal:  Gut       Date:  2007-03-30       Impact factor: 23.059

Review 4.  Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer.

Authors:  Alberto Redaelli; Carole W Cranor; Gary J Okano; Pat Ray Reese
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Workplace colorectal cancer-screening awareness programs: an adjunct to primary care practice?

Authors:  Akshay Bagai; Karen Parsons; Brenda Malone; Julian Fantino; Lawrence Paszat; Linda Rabeneck
Journal:  J Community Health       Date:  2007-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.